Parathyroid Carcinoma Presenting as a Hyperparathyroid Crisis by Tan, Alice Hyun-Kyung et al.
letter to the editor
korean j intern med 2012;27:229-231
http://dx.doi.org/10.3904/kjim.2012.27.2.229 
pISSN 1226-3303    eISSN 2005-6648
http://www.kjim.or.kr
Parathyroid Carcinoma 
Presenting as a 
hyperparathyroid Crisis 
To the Editor,
Although parathyroid carcinoma is a rare cause of hy-
perparathyroidism, it must be included in the differen-
tial diagnosis of parathyroid hormone (PTH)-mediated 
hypercalcemia and hyperparathyroid crisis, which is 
defined as a syndrome characterized by a serum cal-
cium level > 14 mg/dL from a marked elevation of PTH, 
with severe signs and symptoms of hypercalcemia that 
are reversible with a correction of the hypercalcemia 
[1]. Imaging studies may be misleading; thus, careful 
attention to clinical features is important. Manifesta-
tions include mental status changes, nausea, vomiting, 
and abnormal cardiac and renal function. Given the 
recommendations against fine-needle aspiration bi-
opsy (FNAB) of a suspected parathyroid carcinoma, the 
unique surgical approach to its treatment and the im-
plications for family genetic counseling after diagnosis, 
parathyroid carcinoma must not be overlooked in cases 
of hyperparathyroid crisis.
We describe a 46-year-old male who was initially 
referred for renal failure and hypercalcemia. During 
the work-up, he underwent FNAB for a suspicious neck 
nodule, and was diagnosed postoperatively with para-
thyroid carcinoma. He has been cancer-free for 3 years 
following a left superior and inferior parathyroidectomy 
with an en bloc resection of the left thyroid and s/p 
external beam radiation therapy to the tumor bed and 
regional lymphatics. 
Four weeks prior to transfer, the patient presented 
with fever, chills, severe myalgia, anorexia, nausea, dry 
cough, bilateral hand edema, arthralgia, muscle weak-
ness, and pain in the prepatellar region of bilateral low-
er extremities. Routine blood tests revealed an elevated 
serum creatinine of 6.0 mg/dL, severe hypercalcemia 
(serum calcium of 17.42 mg/dL, corrected for albumin), 
elevated intact PTH (1,429.9 pg/mL), and low 1,25 vita-
min D (7.8 pg/mL).
The patient’s medical history was significant only for 
mild to moderate ulcerative colitis. He had no history of 
irradiation to the neck, nephrolithiasis, or pancreatitis. 
Family history was unremarkable. The patient stated 
that he noticed rapid growth of an anterior neck mass 
over the past 4 weeks prior to admission.
A neck exam showed a 4 cm, hard, immobile mass 
in the anterior neck without lymphadenopathy. Heart, 
lung, and abdominal exams were unremarkable, other 
than sinus tachycardia. Edema of the proximal inter-
phalangeal joints of bilateral hands without warmth or 
erythema was noted, and mild effusion and tenderness 
to palpation of bilateral infrapatellar regions was ob-
served. 
The patient was treated with aggressive rehydration 
via intravenous (IV) normal saline and subcutaneous 
calcitonin. On hospital day 9, the patient received one 
dose of 60 mg IV pamidronate. 
A thyroid ultrasound showed a 3.3 × 4.2 cm hetero-
geneous mass in the left lobe of the thyroid with an in-
ternal cystic portion and a calcification segment in the 
periphery (Fig. 1A). This mass was suspected to be an 
indeterminate nodule, and FNAB was performed. The 
smear from the FNAB was consistent with a parathy-
roid proliferative lesion.
A chest computed tomography (CT) scan disclosed 
metastatic calcifications (calcium deposits in the lung 
interstitium) in both lungs and a soft tissue lesion in 
the left thyroid gland area, suspicious of parathyroid 
adenoma. A 
18F-fludeoxyglucose positron emission 
tomography-CT scan (Fig. 1B) revealed a mildly hyper-
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metabolic mass in the left thyroid area, suggestive of a 
benign tumor, such as parathyroid adenoma, and meta-
static calcifications in the lungs, buttocks, and thighs. 
On hospital day 14, the patient received a left superior 
and inferior parathyroidectomy with en bloc resection 
of the left thyroid. 
Histopathology revealed the left parathyroid mass to 
be a 4.5 × 3.0 × 2.0 cm parathyroid carcinoma with fo-
cal vascular, capsular, and soft tissue invasion (Fig. 2A). 
No cancer involvement of the thyroid gland was found, 
and a negative resection margin was achieved. Immu-
nohistochemistry was negative for p53 (1:400, Zymed, 
San Francisco, CA, USA), strong and diffusely positive 
for cyclin D1 (1:100, Novocastra, Newcastle, UK), focally 
positive for retinoblastoma protein (1:50, Novocastra), 
and positive for Ki-67 (1:200, Dako, Glostrup, Denmark) 
in 10% of tumor cells (Fig. 2B).
Given the evidence of capsular invasion on histopa-
thology, adjuvant external beam radiation therapy was 
administered to the tumor bed and regional lymphatics. 
Figure 1. (A) Thyroid ultrasound showing a 3.3 × 4.2 cm heterogeneous mass. (B) A 
18F-fludeoxyglucose positron emission tomography/
computed tomography scan showing a mildly hypermetabolic mass in the left thyroid area.
Figure 2. (A) Gross surgical specimen shows a large parathyroid 
tumor with an irregular border and internal cystic components. 
(B) Histological appearance of parathyroid carcinoma, composed 
of neoplastic chief cells, showing infiltration into the tumor 
capsule and adjacent soft tissue (H&E, × 40).
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On follow-up lung CT, the previously noted metastatic 
calcifications had markedly regressed. The 3-year fol-
low-up thyroid ultrasound showed no recurrence of the 
tumor, and intact PTH was within normal limits.
In a series based on literature review of hyper-
parathyroid crisis from 1978-2007, Phitayakorn and 
McHenry [2] reported that the underlying parathyroid 
abnormality in 192 of 252 cases of hyperparathyroid 
crisis was parathyroid adenoma in 169 (88%), parathy-
roid carcinoma in 10 (5%), parathyroid hyperplasia in 
10 (5%), and parathyroid cysts in five (3%).
It is important to distinguish between these causes 
of hyperparathyroidism prior to surgery because me-
ticulous en bloc resection is the only chance for surgical 
cure of parathyroid cancer, whereas benign parathyroid 
conditions can be treated by adenomectomy or parathy-
roidectomy alone. Additionally, caution must be taken 
to prevent rupture of the tumor capsule in cases of 
parathyroid carcinoma; thus, FNAB should be avoided 
to decrease the chances of tumor seeding, subsequent 
local recurrence, and a worse outcome. 
In a review article on parathyroid carcinoma by Shane 
[3], features that should raise the index of suspicion for 
parathyroid carcinoma rather than benign primary hy-
perparathyroidism include: male gender, younger age, 
serum calcium > 14 mg/dL, serum PTH 3-10 times the 
upper limit of normal, palpable neck mass, recurrent la-
ryngeal nerve palsy, renal involvement, skeletal involve-
ment, concomitant renal and skeletal disease, recurrent 
severe pancreatitis, peptic ulcer disease, anemia, and 
personal or family history of hereditary hyperparathy-
roidism-jaw tumor syndrome.
Since the report by Chow et al. [4] of the success-
ful prevention of locoregional disease progression in 
patients with parathyroid cancer who underwent post-
operative adjuvant radiation therapy, subsequent stud-
ies such as that by Clayman et al. [5]
 have also shown 
promising results. Adjuvant external beam irradiation 
was used in our patient to minimize the risk of local 
recurrence given the evidence of capsular invasion and 
penetration. 
In conclusion, the differential diagnosis must include 
parathyroid carcinoma in patients presenting with hy-
perparathyroid crisis, and special care should be taken 
to avoid rupture of the tumor capsule either preopera-
tively during FNAB or intraoperatively. Although the 
most common cause of hyperparathyroid crisis is para-
thyroid adenoma, the index of suspicion for parathyroid 
carcinoma should be raised in patients with particularly 
elevated levels of PTH and calcium, a palpable neck 
mass, and concomitant bone and renal involvement. 
Aggressive en bloc removal of the affected parathyroid 
gland with ipsilateral thyroidectomy and isthmusecto-
my should be considered in these patients even if imag-
ing suggests that the mass is benign, as this is the only 
chance for a surgical cure of parathyroid cancer. Adju-
vant external beam radiation therapy may be added in 
select cases. 
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